Journal
JOURNAL OF CONTROLLED RELEASE
Volume 167, Issue 2, Pages 130-137Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2013.01.026
Keywords
Liposome extravasation; Mild hyperthermia; Hyperpermeable tumorvasculature; Nanoparticle drug delivery; Intravital confocal microscopy; Whole body optical imaging
Funding
- Stichting Vanderes
- Stichting Fondsen
- SEHK
Ask authors/readers for more resources
Accumulation of nanoparticles in solid tumors depends on their extravasation. However, vascular permeability is very heterogeneous within a tumor and among different tumor types, hampering efficient delivery. Local hyperthermia at a tumor can improve nanoparticle delivery by increasing tumor vasculature permeability, perfusion and interstitial fluid flow. The aim of this study is to investigate hyperthermia conditions required to improve tumor vasculature permeability, subsequent liposome extravasation and interstitial penetration in 4 tumor models. Tumors are implanted in dorsal skin flap window chambers and observed for liposome (similar to 85 nm) accumulation by intravital confocal microscopy. Local hyperthermia at 41 degrees C for 30 min initiates liposome extravasation through permeable tumor vasculature in all 4 tumor models. A further increase in nanoparticle extravasation occurs while continuing heating to 1 h, which is a clinically relevant duration. After hyperthermia, the tumor vasculature remains permeable for 8 h. We visualize gaps in the endothelial lining of up to 10 mu m induced by HT. Liposomes extravasate through these gaps and penetrate into the interstitial space to at least 27.5 mu m in radius from the vessel walls. Whole body optical imaging confirms HT induced extravasation while liposome extravasation was absent at normothermia. In conclusion, a thermal dose of 41 degrees C for 1 h is effective to induce long-lasting permeable tumor vasculature for liposome extravasation and interstitial penetration. These findings hold promise for improved intratumoral drug delivery upon application of local mild hyperthermia prior to administration of nanoparticle-based drug delivery systems. (C) 2013 Elsevier B. V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available